On Monday, August 25, the next meeting of the Transparency Council.
On Monday, August 18, the next meeting of the Transparency Council.
On Monday, June 11, the next meeting of the Transparency Council.
On Tuesday, August 5, the next meeting of the Transparency Council.
On June 27, 2025, Biogen Inc. (Nasdaq: BIIB) announced new data supporting the clinical efficacy of nusinersen in a diverse population of patients suffering from spinal muscular atrophy.
On Monday, August 4, the next meeting of the Transparency Council.
Iwona Schymalla's guest is Dr. Krzysztof Dyrbuś, a cardiologist from the Silesian Center for Heart Diseases in Zabrze.
It will be the first and only molecularly targeted therapy in Europe for the treatment of diffuse glioblastoma grade II, with IDH (isocitrate dehydrogenase) gene mutations. What drug is involved?
On Monday, July 28, the next meeting of the Transparency Council.
National Drug Manufacturers appreciates the contribution of Minister Izabela Leszczyna and the entire leadership and team of the ministry to building Poland's drug security, and hopes that these activities will be continued by the new Minister Jolanta Sobieranska-Grenda.
Wednesday, July 23, is the next meeting of the Transparency Council.
On Monday, July 21, the next meeting of the Transparency Council.
In the face of growing challenges to drug availability in Europe, the Health Ministry has presented a new, expanded version of the National List of Critical Medicines. The document, which is crucial to securing the health needs of Poles, now includes 401 active substances - more than a hundred...
The Health Ministry is analyzing several hundred comments submitted during public consultations on the draft amendment to the Reimbursement Act and assumes that the draft will go to the Parliament soon after the parliamentary vacations. The changes concern, among other things, drug programs.
On Monday, July 14, the next meeting of the AOTMiT Transparency Council.
Anna Gruszczak, MD, from the Department of Neurology, National Medical Institute of the Ministry of Internal Medicine, talks about the first therapeutic breakthrough for ALS patients.
On Monday, July 7, the next meeting of the AOTMiT Transparency Council.
Ministerstwo Zdrowia opublikowało zaktualizowaną listę leków, środków specjalnego przeznaczenia żywieniowego i wyrobów medycznych, których może zabraknąć w polskich aptekach. Wykaz obowiązuje od 10 lipca 2025 roku.
An interview with Prof. Karina Jahnz-Różyk, national consultant in allergology and head of the Department of Internal Medicine, Pneumonology, Allergology, Clinical Immunology and Rare Diseases at the Military Medical Institute in Warsaw.
The Health Ministry publishes an announcement from the Minister of Health regarding medicinal products not subject to financing under the procedure for emergency access to drug technologies.
On Monday, June 30, the next meeting of the Transparency Council.
- Thanks to innovative drugs, we can treat effectively with fewer visits, which means not only convenience for patients, but also real savings for the system," says Professor Robert Rejdak, head of the Department of General Ophthalmology and the Department of Ophthalmology at the Medical...
The Health Ministry has published a list of technologies with a high level of innovation.
Amyotrophic lateral sclerosis (ALS) is a severe and rapidly progressive disease with which patients live an average of 3 to 5 years. Diagnosis is a veritable odyssey, taking up to several years. Now, as never before, genetic testing is becoming crucial, as the world's first therapy has been...
The Health Ministry summarizes the July reimbursement announcement. What news for patients?
On June 12, 2025, during the General Meeting of the Association of Employers of Innovative Pharmaceutical Companies INFARMA, a new Board of Directors and Supervisory Board were elected for another 3-year term. Wiktor Janicki, President of the Management Board of AstraZeneca Pharma Poland, was...
W poniedziałek 16 czerwca kolejne posiedzenie Rady Przejrzystości.
- This is a huge success of the Polish government, which under our presidency led to a compromise among member states on the biggest reform of EU pharmaceutical law in 20 years. We supported these measures in the European forum, because they were aimed at shortening the monopoly of medicines and...
The Health Minister has announced a great success for the Polish Presidency of the EU Council. Member states have adopted a compromise on the so-called pharmaceutical package. The reform means improved access to both innovative and generic drugs.
On Monday, June 9, the next meeting of the AOTMiT Transparency Council.
© 2023 Medexpress. All Rights Reserved
